BFM
OLMA icon

Boothbay Fund Management’s Olema Pharmaceuticals OLMA Stock Holding History

Boothbay Fund Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.35M Buy
157,400
+102,400
+186% +$2.28M 0.03% 551
2025
Q4 		$1.38M Buy
+55,000
New +$979K 0.02% 693

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Boothbay Fund Management's OLMA Position: Q1 2026 in Review

Boothbay Fund Management reduced its Olema Pharmaceuticals (OLMA) stake by 20% in Q1 2026, selling an estimated $990K and leaving 174,603 shares worth $2.6M. The position accounts for 0.03% of the portfolio, ranked #520.

Boothbay Fund Management first reported a position in OLMA in Q3 2024 and has held it in 5 quarters since. The position peaked at $5.48M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Boothbay Fund Management held 174,603 shares of Olema Pharmaceuticals worth $2.6M as of Q1 2026.
  • Boothbay Fund Management sold 44,483 Olema Pharmaceuticals shares in Q1 2026, an estimated $990K.
  • Olema Pharmaceuticals made up 0.03% of Boothbay Fund Management's portfolio in Q1 2026, its #520 holding.
  • Boothbay Fund Management first reported a position in Olema Pharmaceuticals in Q3 2024 and has held it in 5 quarters since.
  • Boothbay Fund Management's Olema Pharmaceuticals position peaked at $5.48M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.